11/13/2024

Mefloquine Hydrochloride Tablets

Products Affected - Description

- Mefloquine hydrochloride oral tablet, Teva, 250 mg, unit-dose blister pack, NDC 00555-0171-78

Reason for the Shortage

- Teva did not provide a reason for the shortage.

Available Products

- There are no presentations available

Estimated Resupply Dates

- Teva has mefloquine 250 mg tablets on back order and the company estimates a release date in early-February 2025.

Alternative Agents & Management

- Healthcare professionals who would like to discuss alternate options for specific populations can contact the CDC malaria clinical consult service at [email protected] or 770-488-7788 Monday to Friday, 9 am to 5 pm EST. Outside these hours, providers can call 770-488-7100.
- See the CDC website for additional information: https://www.cdc.gov/malaria/hcp/drug-malaria/index.html

Updated

Updated November 13, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created October 9, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.